NationalCovaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 MonthsBY Outlook Web Desk
NationalAustralia Recognises Covaxin: All Countries That Have Approved Bharat Biotech's Covid-19 VaccineBY Outlook Web Desk
NationalCovaxin: 7 Countries Allowing Entry To Indians Vaccinated With Bharat Biotech's Covid-19 ShotBY Outlook Web Desk
Making A DifferenceCovid-19 Vaccine: Oman Approves Bharat Biotech's Covaxin Under New Travel RulesBY Outlook Web Desk
National100 Crore Shots: How India Achieved Covid-19 Vaccination Milestone In 280 DaysBY Outlook Web Desk
NationalWHO Technical Group To Meet On Oct 26 To Consider EUL Of Bharat Biotech’s CovaxinBY Outlook Web Desk
NationalCovid Expert Panel Approves Bharat Biotech's Covaxin For Children Between 2-18BY Outlook Web Desk
NationalOver 3.86 Crore People Yet To Get Complete Vaccination Within Stipulated Time: GovtBY Outlook Web Desk
NationalMixing Covaxin and Covishield: India's Drug Authority Gives Nod To Study, TrialsBY Outlook Web Desk
NationalCombination Of Covishield, Covaxin Better Than 2 Doses Of Same Vaccine: ICMR StudyBY Outlook Web Bureau
NationalRevised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health MinisterBY Outlook Web Desk
NationalCovaxin Provides Protection Against Delta Plus Covid Variant: ICMR StudyBY Outlook Web Bureau
NationalCovid-19: Delhi Govt Reserves 40% Covaxin Stock And 20% Covishield Jabs For 1st ShotBY Outlook Web Bureau
Making A DifferenceBrazil Suspends Covaxin’s Clinical Trials After Bharat Biotech Ends Deal With Precisa MedicamentosBY Outlook Web Bureau
NationalHealth Ministry Aware Of 'Some' Controversy Around Covaxin Supply To Brazil: Govt In Lok SabhaBY Outlook Web Bureau
NationalBharat Biotech To Supply 500 Million Covaxin Doses To Centre for Immunisation ProgrammeBY Outlook Web Desk
NationalFather-Daughter Duo Who Risked Life For Vaccine Trial Begs For Jabs For KinBY Jeevan Prakash Sharma
NationalSubmitted Documents To WHO For Covaxin’s Emergency Use Listing: Bharat BiotechBY Outlook Web Bureau